Ignite Creation Date:
2024-05-06 @ 8:40 AM
Last Modification Date:
2024-10-26 @ 12:03 PM
Study NCT ID:
NCT02795325
Status:
TERMINATED
Last Update Posted:
2024-07-11
First Post:
2016-05-18
Brief Title:
A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 PH1
Sponsor:
Dicerna Pharmaceuticals Inc a Novo Nordisk company
Organization:
Novo Nordisk AS
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Primary Hyperoxaluria Type 1 |
Keywords:
| Name | View |
|---|---|
| DCR-PH1 | View |
| Primary Hyperoxaluria Type 1 | View |
| PH1 | View |
| Calcium Oxalate Stones | View |
| Kidney Stones | View |
| Liver Enzyme Deficiency | View |
| Genetic Diseases | View |
| Inborn Kidney Diseases | View |
| Metabolic Diseases | View |
| Inborn Errors | View |
| Urological Diseases | View |
| Carbohydrate Metabolism | View |
| Hyperoxaluria | View |
| AGT | View |
| RNAi | View |
| siRNA | View |